• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Start-up builds PET/CT centers

Article

A new company, Morningstar Molecular Imaging, is hatching plans to launch a chain of PET/CT imaging centers across the U.S. The Sarasota, FL, firm will open its first centers in Georgia, Colorado, and Florida later this year. It plans to expand to other

A new company, Morningstar Molecular Imaging, is hatching plans to launch a chain of PET/CT imaging centers across the U.S. The Sarasota, FL, firm will open its first centers in Georgia, Colorado, and Florida later this year. It plans to expand to other states over the next 12 months. The centers will conduct business under the Morningstar Molecular Imaging name and will be jointly owned by Morningstar, local investors, and physicians where appropriate. The business model is based on three strategies: to cluster multiple imaging centers in metropolitan areas so as to establish economies of scale and local branding; provide only PET/CT through the highest performance, LSO-based scanning systems; and tie all its centers together with an IT system that supports referring physician and patient services. Key to the success of this model is a "speed-to-market" approach to ensure that the fledgling company provides service to patients in as many metro areas as soon as possible, according to Ken Manning, vice president of marketing for Morningstar.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.